Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma

Table 1 The etiologies of liver disease among hepatocellular carcinoma related liver transplant recipients following the implementation of model for end-stage liver disease system in 2002 for prioritizing of patients for liver transplant[12]

Etiologies of HCC	HCC patients undergoing livertransplantation in the MELD era
	2002	2007	2012
HCV	43.4%	46.3%	49.9%
NASH	0%	4.0%	6.0%
ALD + HCV	4.9%	6.5%	6.4%
HBV	10.2%	8.3%	4.6%
Modified NASH	8.3%	10.3%	13.5%

HCC: Hepatocellular carcinoma; MELD: Model for end-stage liver disease; HCV: Hepatitis C virus; NASH: Nonalcoholic steatohepatitis.